2018 annual financial data
XTL Biopharmaceuticals 2018 Net income growth
Direct answer
Net income growth was 482.33%.
Operating income was -793,000 USD and net income was 2,986,000 USD.
Operating cash flow was -816,000 USD.
Get free XTL Biopharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 52,000 USD
- Operating income
- -793,000 USD
- Net income
- 2,986,000 USD
- Operating cash flow
- -816,000 USD